Coffee consumption and risk of non-hodgkin’s lymphoma

A. Tavani, E. Negri, C. La Vecchia

Research output: Contribution to journalArticle

Abstract

There is no adequate information on the carcinogenicity of coffee and, specifically, on a potential association of coffee drinking with non-Hodgkin's lymphoma. Consumption of coffee and other methylxanthine-containing beverages has been researched in a case-control study conducted in northern Italy. A total of 429 cases of incident histologically confirmed non-Hodgkin's lymphoma and 1,157 controls in hospital for acute, non-neoplastic, non-immunological, non-digestive tract diseases were interviewed during their hospital stay. Relative risk (RR) estimates and their 95% confidence intervals (CI), according to consumption of coffee and other methylxanthine-containing beverages, were derived from multiple logistic regression equations including terms for age. sex, study centre, body mass index, alcohol and smoking status. Compared with non-drinkers, the RR was 1.2 (95% CI, 0.8–1.7) for coffee drinkers. No trend in risk emerged with number of cups of coffee consumed/day (RR = 1.1 for one and three cups; RR = 1.2 for two; or RR = 0.9 for four cups/day), or duration of coffee intake (RR = 1.2 for less than 20 years; RR = 1.3 for 21–30 years; and RR = 1.1 for more than 30 years). Similarly. no significant association was observed with consumption of decaffeinated coffee (RR = 0.9) or tea (RR = 1.2). Consumption of cola was associated with a borderline risk (RR = 1.7; 95% CI 1.0–2.7). We found no association between non-Hodgkin's lymphoma and consumption of regular or decaffeinated coffee and tea.

Original languageEnglish
Pages (from-to)351-356
Number of pages6
JournalEuropean Journal of Cancer Prevention
Volume3
Issue number4
Publication statusPublished - 1994

Fingerprint

Coffee
Non-Hodgkin's Lymphoma
Beverages
Tea
Confidence Intervals
Italy
Drinking
Case-Control Studies
Length of Stay
Body Mass Index
Logistic Models
Smoking
Alcohols

Keywords

  • Case-control studies
  • Coffee
  • Neoplasm prevention
  • Non-hodgkin's lymphoma
  • Risk factors
  • Tea

ASJC Scopus subject areas

  • Cancer Research
  • Epidemiology
  • Oncology
  • Public Health, Environmental and Occupational Health

Cite this

Tavani, A., Negri, E., & Vecchia, C. L. (1994). Coffee consumption and risk of non-hodgkin’s lymphoma. European Journal of Cancer Prevention, 3(4), 351-356.

Coffee consumption and risk of non-hodgkin’s lymphoma. / Tavani, A.; Negri, E.; Vecchia, C. La.

In: European Journal of Cancer Prevention, Vol. 3, No. 4, 1994, p. 351-356.

Research output: Contribution to journalArticle

Tavani, A, Negri, E & Vecchia, CL 1994, 'Coffee consumption and risk of non-hodgkin’s lymphoma', European Journal of Cancer Prevention, vol. 3, no. 4, pp. 351-356.
Tavani, A. ; Negri, E. ; Vecchia, C. La. / Coffee consumption and risk of non-hodgkin’s lymphoma. In: European Journal of Cancer Prevention. 1994 ; Vol. 3, No. 4. pp. 351-356.
@article{d924efce64bb4ead9118aad50f407e8c,
title = "Coffee consumption and risk of non-hodgkin’s lymphoma",
abstract = "There is no adequate information on the carcinogenicity of coffee and, specifically, on a potential association of coffee drinking with non-Hodgkin's lymphoma. Consumption of coffee and other methylxanthine-containing beverages has been researched in a case-control study conducted in northern Italy. A total of 429 cases of incident histologically confirmed non-Hodgkin's lymphoma and 1,157 controls in hospital for acute, non-neoplastic, non-immunological, non-digestive tract diseases were interviewed during their hospital stay. Relative risk (RR) estimates and their 95{\%} confidence intervals (CI), according to consumption of coffee and other methylxanthine-containing beverages, were derived from multiple logistic regression equations including terms for age. sex, study centre, body mass index, alcohol and smoking status. Compared with non-drinkers, the RR was 1.2 (95{\%} CI, 0.8–1.7) for coffee drinkers. No trend in risk emerged with number of cups of coffee consumed/day (RR = 1.1 for one and three cups; RR = 1.2 for two; or RR = 0.9 for four cups/day), or duration of coffee intake (RR = 1.2 for less than 20 years; RR = 1.3 for 21–30 years; and RR = 1.1 for more than 30 years). Similarly. no significant association was observed with consumption of decaffeinated coffee (RR = 0.9) or tea (RR = 1.2). Consumption of cola was associated with a borderline risk (RR = 1.7; 95{\%} CI 1.0–2.7). We found no association between non-Hodgkin's lymphoma and consumption of regular or decaffeinated coffee and tea.",
keywords = "Case-control studies, Coffee, Neoplasm prevention, Non-hodgkin's lymphoma, Risk factors, Tea",
author = "A. Tavani and E. Negri and Vecchia, {C. La}",
year = "1994",
language = "English",
volume = "3",
pages = "351--356",
journal = "European Journal of Cancer Prevention",
issn = "0959-8278",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Coffee consumption and risk of non-hodgkin’s lymphoma

AU - Tavani, A.

AU - Negri, E.

AU - Vecchia, C. La

PY - 1994

Y1 - 1994

N2 - There is no adequate information on the carcinogenicity of coffee and, specifically, on a potential association of coffee drinking with non-Hodgkin's lymphoma. Consumption of coffee and other methylxanthine-containing beverages has been researched in a case-control study conducted in northern Italy. A total of 429 cases of incident histologically confirmed non-Hodgkin's lymphoma and 1,157 controls in hospital for acute, non-neoplastic, non-immunological, non-digestive tract diseases were interviewed during their hospital stay. Relative risk (RR) estimates and their 95% confidence intervals (CI), according to consumption of coffee and other methylxanthine-containing beverages, were derived from multiple logistic regression equations including terms for age. sex, study centre, body mass index, alcohol and smoking status. Compared with non-drinkers, the RR was 1.2 (95% CI, 0.8–1.7) for coffee drinkers. No trend in risk emerged with number of cups of coffee consumed/day (RR = 1.1 for one and three cups; RR = 1.2 for two; or RR = 0.9 for four cups/day), or duration of coffee intake (RR = 1.2 for less than 20 years; RR = 1.3 for 21–30 years; and RR = 1.1 for more than 30 years). Similarly. no significant association was observed with consumption of decaffeinated coffee (RR = 0.9) or tea (RR = 1.2). Consumption of cola was associated with a borderline risk (RR = 1.7; 95% CI 1.0–2.7). We found no association between non-Hodgkin's lymphoma and consumption of regular or decaffeinated coffee and tea.

AB - There is no adequate information on the carcinogenicity of coffee and, specifically, on a potential association of coffee drinking with non-Hodgkin's lymphoma. Consumption of coffee and other methylxanthine-containing beverages has been researched in a case-control study conducted in northern Italy. A total of 429 cases of incident histologically confirmed non-Hodgkin's lymphoma and 1,157 controls in hospital for acute, non-neoplastic, non-immunological, non-digestive tract diseases were interviewed during their hospital stay. Relative risk (RR) estimates and their 95% confidence intervals (CI), according to consumption of coffee and other methylxanthine-containing beverages, were derived from multiple logistic regression equations including terms for age. sex, study centre, body mass index, alcohol and smoking status. Compared with non-drinkers, the RR was 1.2 (95% CI, 0.8–1.7) for coffee drinkers. No trend in risk emerged with number of cups of coffee consumed/day (RR = 1.1 for one and three cups; RR = 1.2 for two; or RR = 0.9 for four cups/day), or duration of coffee intake (RR = 1.2 for less than 20 years; RR = 1.3 for 21–30 years; and RR = 1.1 for more than 30 years). Similarly. no significant association was observed with consumption of decaffeinated coffee (RR = 0.9) or tea (RR = 1.2). Consumption of cola was associated with a borderline risk (RR = 1.7; 95% CI 1.0–2.7). We found no association between non-Hodgkin's lymphoma and consumption of regular or decaffeinated coffee and tea.

KW - Case-control studies

KW - Coffee

KW - Neoplasm prevention

KW - Non-hodgkin's lymphoma

KW - Risk factors

KW - Tea

UR - http://www.scopus.com/inward/record.url?scp=0027993466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027993466&partnerID=8YFLogxK

M3 - Article

C2 - 7950889

AN - SCOPUS:0027993466

VL - 3

SP - 351

EP - 356

JO - European Journal of Cancer Prevention

JF - European Journal of Cancer Prevention

SN - 0959-8278

IS - 4

ER -